Neurovalens

company

About

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
£4.60M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and
neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£5.70M $750K
Neurovalens has raised a total of £5.70M $750K in funding over 2 rounds. Their latest funding was raised on Oct 15, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 15, 2019 Series Unknown $750K 1 Growth Finance Fund Detail
Mar 14, 2019 Series A £4.60M 1 Detail
Jul 19, 2017 Seed £1.10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Neurovalens is funded by 2 investors. Growth Finance Fund and Beltrae Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Growth Finance Fund Yes Series Unknown
Beltrae Partners Series A